Furthermore, plasma BDNF alone accounted for 19-24% (R2=0.19 to 0.24) of the variance explained in each of the cognitive domains, providing further support for its potentially prominent functions in modulating cognition in preclinical dementia. This evidence concerns the gene BDNF and dementia.